19.14USD-1.34%Mkt Cap: 726.22M $P/E: —1d ago
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the ac…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap726.22M $
Enterprise Value607.16M $
Revenue (TTM)95.07M $
Gross Profit78.27M $
Net Income (TTM)-53.41M $
Revenue/Share2.570 USD
Last Price19.14 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees327
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-17.43
PEG—
EV/EBITDA-9.53
EV/Revenue6.39
P/S7.64
P/B5.15
EPS (TTM)-1.62
EPS (Forward)-1.10
52W Range
10.8561% of range24.33
52W High24.33 USD
52W Low10.85 USD
Profitability
Gross Margin87.89%
Oper. Margin-78.30%
EBITDA Margin-67.00%
Profit Margin-59.97%
ROE-34.38%
ROA-27.28%
Growth
Revenue Growth29.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-40.81M $
CapEx (TTM)767.00K $
FCF Margin-30.86%
FCF Yield-4.04%
Net Debt-119.07M $
Net Debt/EBITDA1.87
Balance Sheet
Debt/Equity0.14
Current Ratio10.44
Quick Ratio9.70
Book Value/Sh3.719 USD
Cash/Share3.721 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)26.86 USD
Upside (mean)+40.3%
Target Range24.00 USD – 32.00 USD
$24.00+40.3% to mean$32.00
# Analysts7
Ownership
Shares Out.37.94M
Float26.06M
Insiders12.79%
Institutions86.91%
Short Interest
Short Ratio5.3d
Short % Float8.03%
Short % Out.5.21%
Shares Short1.98M
Short (prev mo.)1.92M
Technical
SMA 5018.71 (+2.3%)
SMA 20018.13 (+5.6%)
Beta—
S&P 52W Chg20.25%
Avg Vol (30d)358.48K
Avg Vol (10d)342.23K
Technical Indicators
RSI (14)49.9
MACD0.2030
MACD Signal0.2580
MACD Hist.-0.0550
BB Upper20.73 USD
BB Middle19.23 USD
BB Lower17.73 USD
BB Width15.58%
ATR (14)0.7976 USD
Vol Ratio (20d)1.36x